MEDRAD, Battelle Win Award for Contrast Media Injection Device

 

April 8, 2008

April 8, 2008 - Battelle, a nonprofit independent research and development organization, and MEDRAD Inc. won a Medical Design Excellence Award (MDEA) for the MEDRAD XDS Extravasation Detector, a device for the enhancement of the safety of contrast media injection through early detection of extravasations.

Battelle worked closely with MEDRAD to develop the technology from exploration through product development. MEDRAD and Battelle jointly invented the electrical permittivity technology that enables XDS and developed the commercial product.

XDS continuously monitors the tissue immediately surrounding and directly beneath the injection site for changes in relative permittivity signaling fluid accumulation.

The MDEA competition is a prestigious program recognizing medical product excellence and the achievements of medical product manufacturers. An impartial, multidisciplinary panel of jurors with expertise in biomedical engineering, human factors, industrial design, medicine and diagnostics reviewed the entries and selected the winners.

MEDRAD and Battelle will accept the award at a ceremony on June 4, 2008 at the Medical Design & Manufacturing (MD&M) East 2008 Conference and Exposition in New York City. Additionally, the MEDRAD XDS Extravasation Detector will appear with the other MDEA winners in the April 7 issue of Medical Device & Diagnostic Industry (MD&DI).

For more information: www.medrad.com and www.battelle.org